PD Dr. Marlen Haderlein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prognostic Significance of immune-associated Side Effects under Radioimmunotherapy and Immunotherapy alone in Patients of the prospective ST-ICI Study (2020) Schweizer C, Schubert P, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, Becker I, et al. Conference contribution Use of NGS Gene Panel Analyzes for molecularly targeted System Therapy (2020) Roesch J, Haller F, Lettmaier S, Haderlein M, Hartmann A, Moskalev E, Tögel L, et al. Conference contribution Comparison of Intrinsic PAM50 Gene Expression Analysis and Immunohistochemical Subtypes of Salivary Duct Carcinoma (2020) Erber R, Stoehr R, Haller F, Haderlein M, Hartmann A, Agaimy A Conference contribution Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: First (treatment planning) results of the prospective multicenter DIREKHT trial (2020) Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, et al. Journal article Secondary Tracheoesophageal Puncture After Laryngectomy Increases Complications With Shunt and Voice Prosthesis (2020) Scherl C, Kauffels J, Schützenberger A, Döllinger M, Bohr C, Dürr S, Fietkau R, et al. Journal article Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer (2020) Müller SK, Mantsopoulos K, Semrau S, Agaimy A, Eckstein M, Traxdorf M, Gostian AO, et al. Journal article Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) Rudolf J, Büttner-Herold M, Erlenbach-Wuensch K, Posselt R, Jeßberger J, Haderlein M, Hecht M, et al. Journal article Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020) Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al. Journal article Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? (2019) Mayo T, Haderlein M, Schuster B, Wiesmueller A, Hummel C, Bachl M, Schmidt M, et al. Journal article Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results (2019) Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Müller SK, et al. Journal article
1 ... 3 4 5 6 7 8